Obesity and breast cancer: a lost lipid defense

The relationship between obesity and breast cancer is usually discussed in terms of what excess adipose tissue adds: inflammatory signals, altered hormones, and metabolites that can favor tumor growth. A study published in Science reveals a different possibility. Obesity may also remove a naturally occurring tumor-suppressive signal from breast fat. At the center of that pathway is a lipid called 9S-HODE.

A defense that can disappear

Breast tissue contains abundant fat, and its adipocytes do much more than store energy. They release a broad range of molecules that can influence neighboring cells.

The researchers compared mammary adipocytes from lean and obese mice. Material secreted by lean adipocytes strongly restrained the growth of multiple mouse and human breast cancer cell lines, whereas adipocytes from obese tissue had largely lost this activity.

The team then searched for the factor responsible. Lipidomic analysis pointed not to a protein but to an oxylipin — a bioactive oxidized lipid derived from a polyunsaturated fatty acid. The molecule was 9S-hydroxyoctadecadienoic acid, or 9S-HODE, which is derived from linoleic acid.

Its effect on cancer cells was striking. 9S-HODE disrupted intracellular iron homeostasis and triggered ferroptosis.

Ferroptosis is a form of cell death driven by iron-dependent lipid oxidation. When lipid peroxides accumulate beyond the cell's ability to control them, cellular membranes are damaged and the cell dies. It is mechanistically distinct from classical apoptosis.

A brake on tumor growth

The researchers then tested whether this pathway mattered inside tumors. Breast tumors growing in lean mice showed more evidence of ferroptotic stress than tumors in obese mice. When ferroptosis was pharmacologically blocked, tumors in lean animals grew faster. The same intervention had little effect in obese mice, where this protective pressure was already diminished.

That result changes the framing of the obesity–cancer relationship. The difference was not simply that obesity created a more tumor-friendly environment. Lean adipose tissue itself was actively imposing a constraint on tumor growth.

The reverse experiment strengthened that interpretation. If obesity reduces 9S-HODE, could restoring the lipid restore some of the lost pressure on the tumor?

The researchers injected 9S-HODE directly into breast tumors in obese mice. Tumor growth was suppressed. This was a preclinical experiment, not a treatment trial, but it supported the proposed causal chain: loss of 9S-HODE reduces ferroptotic pressure, whereas restoring the lipid can make the tumor environment less permissive.

The connection to human tissue

The study also included human evidence. In mammary adipose tissue, 9-HODE abundance was inversely correlated with body mass index: higher BMI was associated with lower levels of the lipid.

That observation is a correlation and does not establish that reduced 9-HODE causes breast cancer in people. A second experiment, however, showed that 9S-HODE could suppress the growth of patient-derived breast cancer organoids. These three-dimensional tumor cultures provide a way to test how human cancer tissue responds outside the body.

The therapeutic implications remain preliminary. Most of the causal evidence comes from mouse and cell models. The study does not show that administering 9S-HODE is safe or effective in patients, nor does it establish how such a pathway could be manipulated systemically. Obesity also influences breast cancer through many other biological mechanisms, so this lipid signal is one piece of a much larger network.

What makes the finding particularly interesting is its direction. Obesity may promote breast cancer not only by pressing biological accelerators, but also by removing a brake that was already present in the local tissue.